Lyme disease vaccine ‘shows over 70% efficacy’ in late-stage trial Lyme disease vaccine ‘shows over 70% efficacy’ in late-stage trial A new vaccine candidate developed by Pfizer for Lyme disease has reportedly ‘demonstrated more than 70 per...Read More
